Obesity and related diseases such as colorectal cancer are an important clinical problem in highly developed countries. In this article, the relationship between the occurrence of these diseases and the gut microbiome is presented on the basis of scientific research. The gut microbiome increases the energy value of consumed meals by breaking down to simpler substances not digested by human enzymes, and is involved in the regulation of lipid and glucose metabolism in the body. A proper microbiota influences the formation of SCFAs, or short-chain fatty acids, which have a protective effect on intestinal cells.  Intestinal dysbiosis affects endotoxaemia and inflammation, which accompanies cancer and obesity.

Introduction and Purpose: Multiple sclerosis (MS) is an autoimmune disease that damages the nervous system. Although MS is usually diagnosed in adults, it can also occur in children and adolescents, which presents diagnostic and therapeutic challenges. In recent years, attention has been drawn to the role of diet in alleviating MS symptoms, including in the pediatric population. The ketogenic diet, characterized by low carbohydrate intake, high fat intake, and moderate protein intake, is of interest as an additional therapeutic approach in MS due to its effects on metabolism and reduction of inflammation in the body.   Materials and methods: This article reviews the literature on the impact of the ketogenic diet on MS, with particular emphasis on its impact on the course of MS in the pediatric population. Articles were searched by key words, e.g. multiple sclerosis, paediatrics, children, diet, ketogenic diet, in various configurations, in Scopus, Medline, Google Scholar databases.   Current state of knowledge: While there are several studies on the effects of the ketogenic diet, including those on MS in children, the results are inconclusive and require further research. Some publications suggest that the ketogenic diet can help alleviate MS symptoms, such as problems with balance and coordination, and improve patients' quality of life.   Conclusions: In conclusion, the ketogenic diet may be a promising approach in the treatment of pediatric MS, but requires further research and careful assessment of benefits and risks before its introduction into therapy.

Introduction: Chronic Kidney Disease (CKD) has become one of the most common chronic diseases of the XXI century and affects around 16% of the world's population. Despite the advancements of contemporary science and a range of therapeutic methods it considered a progressive and irreversible process. Nevertheless, use of ACEI halts the progression of the disease and postpones the necessity of renal replacement therapy and is the method of choice for this group of patients.  Purpose of the work: The article reviews current literature and writing regarding Chronic Kidney Disease (CKD) and the impact of ACEI on the progression of this condition.  Materials and methods: The sources available in the PubMed database have been analyzed using the keywords: “ACEI”, “angiotensin-converting-enzyme inhibitors”, ”chronic kidney disease”, “CKD”. Related publications to the topic of the work have been selected and utilized.  Description of the state of knowledge: Pharmacological therapy using ACEI is the main method of treatment for patients with CKD and should primarily serve to reduce proteinuria and control blood pressure. It inhibits the progression of the disease and delays the development of end-stage renal failure. However, the treatment of CKD using ACEI is controversial in cases of advanced stages of the disease.  Summary: ACEI inhibitors are one of the major advances in the treatment of patients dealing with CKD. Due to the increasing number of cases of the disease being observed, further research will be needed regarding the use of these drugs. Particularly ambiguous is the therapy for patients with advanced, just before end-stage renal failure, which will require a more in-depth analysis of these cases.

Objective: The aim of the study was to draw attention to the problem of overweight and obesity among children and adults. Another important aspect of this article was to indicate the need of promotion a healthy lifestyle as a way to reduce body weight.  Methods: Available literature was reviewed for the purpose of writing this article. Using keywords such as obesity, overweight, pandemics, diet, lifestyle, chronic diseases, metabolic disorders- PubMed was searched. Results: The incidence of overweight and obesity is constantly increasing. This phenomenon is observed all over the world. Obesity has become a pandemic of the 21st century. Consumption of unhealthy, highly processed food is increasing these days. In addition, sedentary lifestyle is very popular. Lifestyle and diet changes are the main causes of this pandemic. The SARS-CoV-2 virus also had an impact on the development of the obesity and overweight pandemic. Obesity affects the quality of life and causes many chronic diseases. The effects on the community are also significant. Obesity and related diseases like diabetes, ischemic heart disease, heart attacks, asthma result in high health care costs. Conclusion: The percentage of overweight and obese people around the world is increasing. It is necessary to promote healthy eating, active lifestyle and look for alternative ways to reduce the scale of overweight and obesity problem.

Osteoarthritis is one of the most common chronic diseases, which is characterized by the destruction of joint cartilage and leads to changes in the structure of other joint elements, the formation of osteophytes and the development of inflammation in the immediate area. Precise assessment of the frequency and distribution of the disease in the population may be difficult due to the inconsistent definition of the disease and the selected diagnostic criteria, but it is estimated that it may occur in up to 60% of the elderly population, more often in women than men. There are many documented risk factors for the occurrence of the disease, such as age or genetic predisposition, but the modifiable ones deserve special attention. Recently, great emphasis in the context of osteoarthritis has been put on the fight against obesity, which not only increases the mechanical load on the joints, but also intensifies the generalized inflammation in the cartilage and its surroundings. This is one of the reasons why non-pharmacological therapy, i.e. patient education and physiotherapy, is a basic element of management, both alone and in combination with pharmacological treatment. The most common drugs used in OA are non-opioid analgesics from the lowest level of the analgesic ladder - mainly NSAIDs, and their proven effectiveness is consistent with the current concept of inflammation as the main pathogenetic factor. As a second-line treatment, injections of glucocorticoids, hyaluronic acid (HA) and platelet-rich plasma (PRP) directly into the joint may be considered. Unfortunately, most randomized studies show that the administration of steroids is effective, but the effects are relatively short-lived, up to a few weeks, while more reliable scientific evidence is needed to confirm the effectiveness of other substances.